Therefore, the inflammation in rosacea can be modulated by inhibiting the generation of LL-37 via inhibition of KLK5 activity, or by directly blocking the release of inflammatory mediators induced by LL-37 in mast cells. This evidence concerns the gene KLK5 and rosacea.